狮门影业 LION
$14.24 +$1.68 (+13.38%)
休市 · Nov 6, 9:40 pm ET · 最新盘后价 $14.24 0.00%
开盘$12.75
昨收$12.56
当日区间$12.49 – $14.31
成交量12.76M
市值$4.24B
市盈率（TTM）–
股息率–
LION 相关新闻
匹配 Lionsgate Studios 或代码 LION 的头条新闻，按最新排序。
- Lion: Amendment Report (Securities Subject to Special Treatment, etc.)
- J.P. Morgan Initiates Lionsgate Studios(LION.US) With Sell Rating, Announces Target Price $9
- Press Release: Lion Group Holding Ltd. Reaffirms Long-Term Commitment to Hyperliquid (HYPE) Holdings
- Press Release: MetaOptics Secures up to US$10 Million Investment Facility From White Lion Capital, Its First U.S. Institutional Investor, to Onshore Metalens Technology Into the U.S.
- Morgan Stanley Maintains Lionsgate Studios(LION.US) With Buy Rating, Maintains Target Price $15
- Citizens JMP Initiates Lionsgate Studios(LION.US) With Buy Rating, Announces Target Price $18
- Jefferies Maintains LION CORP(LIOPF.US) With Hold Rating, Raises Target Price to $12.05 正面
- Analysts Offer Insights on NA Companies: Springer Nature AG & Co. KGaA (OtherSPGDF), Lionsgate Studios (LION) and Tandem Diabetes Care (TNDM)
- Seaport Global Maintains Lionsgate Studios(LION.US) With Buy Rating, Raises Target Price to $17 正面
- Wells Fargo Maintains Lionsgate Studios(LION.US) With Buy Rating, Maintains Target Price $16
- Lion: Notice Regarding Investment in a U.S.-based Venture Capital Fund Specializing in Oral Healthcare Startups
- Morgan Stanley Maintains Lionsgate Studios(LION.US) With Buy Rating, Raises Target Price to $15 正面
- Lion: Notice Regarding Investment in a U.S. Venture Capital Fund Specializing in Oral Health Care Startups
- J.P. Morgan Maintains LION FINANCE GROUP PLC(BDGSF.US) With Buy Rating, Raises Target Price to $190.23 正面
- Barrington Maintains Lionsgate Studios(LION.US) With Buy Rating, Maintains Target Price $17
暂无评论——快来第一个聊聊 LION。
登录后参与讨论。